What is IPF Phase III CAPACITY 1 (pirfenidone)?
CATEGORY:
TYPES:Generic: Pirfenidone
The CAPACITY 1 trial was a Phase III, placebo controlled trial of the safety and efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis. NCT00287729
Save up to 80% off your prescriptions!
We currently don't have enough shared data that is made public for this treatment.
Let's build this page together! When you share what it's like to have IPF Phase III CAPACITY 1 (pirfenidone) through your profile, those stories and data appear here too.
Learn more about our community’s experience with IPF Phase III CAPACITY 1 (pirfenidone)
What are people saying about IPF Phase III CAPACITY 1 (pirfenidone)?
2
2
members have reported taking IPF Phase III CAPACITY 1 (pirfenidone)
Join the conversation and connect with people who have taken IPF Phase III CAPACITY 1 (pirfenidone)
Last updated: